Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1107 (LINC01107) is a member of the long non-coding RNA family, defined by transcripts longer than 200 nucleotides that do not overlap known protein-coding genes[1][3][5]. LINC01107 is annotated in the human genome and may regulate gene expression, chromatin structure, or transcriptional processes—functions broadly attributed to lincRNAs[3][7]. There are references to its differential expression across multiple cancer types, suggesting its potential relevance in disease-specific molecular classifications, but its mechanistic role and therapeutic potential remain under-researched[6]. Currently, LINC01107 is not considered a direct therapeutic target, nor are there drugs or safety concerns associated with clinical modulation of its expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1107 (LINC01107).